Moderna announced a $750 million funding boost from Blackstone Life Sciences to its influenza mRNA vaccine program. “We combine scale capital with deep clinical development expertise to help advance innovative medicines and technologies with the potential to transform patients’ lives. Our team invests across the life cycle of companies and products in a range of therapeutic areas‚” Blackstone Life Sciences states on its website. “Moderna on Wednesday said Blackstone’s life sciences arm would offer $750 million to help fund development of its flu vaccines‚ bolstering the company’s efforts to advance multiple vaccines in the face of a steep decline in sales of its COVID-19 shots‚” Reuters reports. “Blackstone Life Sciences will get commercial milestone payments and low-single digit royalties on the influenza vaccine as part of the agreement‚ said Moderna‚ whose current lone marketed product is its COVID-19 shot. Moderna will also pay Blackstone a proportional royalty on the combination vaccine against influenza and COVID‚ if it is approved‚ based on the fair value for the flu component‚” Chief Nerd cited. “Moderna on Wednesday said Blackstone's life sciences arm would offer $750 million to help fund development of its flu vaccines‚ bolstering the company's efforts to advance multiple vaccines in the face of a steep decline in sales of its COVID-19 shots. Blackstone Life Sciences… pic.twitter.com/lsY9MgZ6oq — Chief Nerd (@TheChiefNerd) March 27‚ 2024 Fierce Biotech reports: Moderna will be using the funding infusion to subsidize the program rather than swell the amount of money available to its flu research. “Moderna expects to recognize the funding as a reduction in research and development expenses and will retain full rights and control of the company’s flu program‚” the biotech explained. “This funding does not result in any change to Moderna’s 2024 research and development framework of approximately $4.5 billion.” Moderna CEO Stéphane Bancel said the funding agreement would contribute to the company’s goal of launching “multiple vaccine products in the next few years.” “Achieving this ambition requires substantial investment in late-stage studies and we are excited to welcome Blackstone and their innovative financing model‚” Bancel added. Moderna’s flu program suffered some initial setbacks‚ with a previous version of the seasonal flu candidate mRNA-1010 failing to meet the noninferiority threshold for two influenza B strains a year ago. But by September 2023 the company was back on track‚ with an updated formula of the shot besting GSK’s Fluarix in phase 3. Moderna secures $750 mln from Blackstone Life Sciences to develop flu shots https://t.co/qJYzXH8hdo pic.twitter.com/aJioaMoKde — Reuters (@Reuters) March 27‚ 2024 Blackstone Life Sciences‚ a private investment company‚ is making a big bet on its Cambridge neighbor Moderna‚ the drug firm that has made multiple versions of a vaccine to fend off COVID-19. https://t.co/8HVPkHTLW0 — The Boston Globe (@BostonGlobe) March 27‚ 2024 “Moderna is developing several new vaccines‚ including for cancer and respiratory syncytial virus (RSV)‚ resulting in high research and development spending‚” Reuters noted. “It allows us to accelerate into new programs. It allows us to diversify our revenue stream and it reduces the risk‚ frankly‚ of the flu program as well‚” Moderna Chief Financial Officer James Mock commented. Per Reuters: The company would consider this project financing model for other experimental vaccines‚ if there is a need‚ he added. Moderna plans to move three vaccines to late-stage trials this year‚ including one against the varicella-zoster virus that can cause shingles and another against the pathogen that causes infectious mononucleosis‚ commonly known as mono. Moderna shares were up about 2% in afternoon trading.

The United States of America is at a low point in its history. Is it too late to turn it all around? Bill breaks down the importance of the 2024 election.

Bernard Goldberg joins The No Spin News to talk about the media’s collapse in the wake of Donald Trump’s election.

Donald Trump will attend the wake of slain NYPD officer Jonathan Diller on Long Island‚ NY Thursday as Joe Biden holds a massive NYC fundraiser alongside Bill Clinton and Barack Obama. Yesterday evening‚ Police Officer Jonathan Diller received a dignified transfer home. Jonathan was killed while protecting the City of New York. We will never forget the ultimate sacrifice that was made by Jonathan and his family. pic.twitter.com/LQOyUX9Aed— NYPD NEWS (@NYPDnews) March 27‚ 2024 JUST IN: Over 1000 NYPD officers gather to honor NYPD Officer Jonathan Diller who was killed by career criminal Guy Rivera.RIP.Diller was shot in the stomach in Queens and could be seen on surveillance footage dragging himself behind a car‚ screaming out in pain.The… pic.twitter.com/Pvw8SdzySQ— Collin Rugg (@CollinRugg) March 27‚ 2024 BREAKING: NBC confirms that Trump will be attending the wake for Officer Diller in NYC tomorrow.Diller was kiIIed by a career criminal with 21 previous arrests and nine felony charges.Still no comment from Biden or the WH. pic.twitter.com/3YW6hyQ7FL— End Wokeness (@EndWokeness) March 27‚ 2024 From ABC New York: The heartbroken loved ones of fallen NYPD Officer Jonathan Diller will gather Thursday to say their final goodbyes at his first wake. The NYPD made arrangements for Former President Donald Trump to attend the first wake at 2 p.m. “President Trump is moved by the invitation to join NYPD Officer Jonathan Diller’s family and colleagues as they deal with his senseless and tragic death‚” a spokesperson for Trump said. Diller was on the force for three years and leaves behind a wife and an almost 1-year-old son. He was fatally shot in Queens during what should have been a routine traffic stop. Tributes continued in Queens Wednesday evening as Diller’s colleagues gathered outside the 105th precinct for a vigil‚ where many heads were bowed. Firefighters and other first responders attended‚ joining together for prayer.

Australian prog trio The Omnific will tour Europe and the UK this summer

Missing his pal Peter Gabriel and sensing more change in the air with Genesis‚ the guitarist overcame his confidence issues to become the first member to release a solo album

Hellyeah and Mudvayne singer Chad Gray says late drummer Vinnie Paul never wanted Pantera to reunite following the death of his brother Dimebag Darrell

Want to hear the very best of this week's alt. rock bangers? Step inside‚ walk this way‚ etc‚.